Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Franklin FTSE South Korea ETF (FLKR) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Franklin FTSE South Korea ETFTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Franklin FTSE South Korea ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? Franklin FTSE South Korea ETF trades at $50 (market cap $1.67B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Franklin FTSE South Korea ETF and Vir Biotechnology Inc. Common Stock are close in size by market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Franklin FTSE South Korea ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Franklin FTSE South Korea ETF for 15 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

FLKRVIR
Market Cap
$1.67B$1.80B
Volume
703,7031,782,836
Sector
Broad Market / FactorHealth
52-Week High
$72.25$11.78
52-Week Low
$28.48$5.12
Typical Hold Time
15 Days0 Days
Enterprise Value
—$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Franklin FTSE South Korea ETF

FLKR (Franklin FTSE South Korea ETF) is trading at $54.89, down 2.03% with a bearish technical signal (16 sell vs 6 buy signals). The ETF faces pressure from semiconductor sector volatility and rising global yields, though some analysts see current levels as a potential buying opportunity. Technical indicators show strong resistance at $55-$56 with support at $53-$54 levels. The fund remains heavily concentrated in Korean memory chip giants Samsung and SK Hynix, making it highly sensitive to AI and semiconductor cycles.

While FLKR faces near-term headwinds from semiconductor volatility and macroeconomic pressures, long-term prospects remain tied to AI-driven demand for Korean tech. The current discount to growth expectations presents opportunity, but investors must weigh concentration risk against potential semiconductor recovery. Key risks include political tensions, currency fluctuations, and global interest rate environment.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FLKR

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Franklin FTSE South Korea ETF

Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.

Read more on FLKR →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →